Sharma Abhinav, Birring Paramveer, Acharya Nischal, Mehta Manaav, Goldenhersh Nicole, Steinhaus Michael, Buser Zorica, Wu Hao-Hua, Hashmi Sohaib, Park Don Young, Lee Yu-Po, Bhatia Nitin
Department of Orthopaedic Surgery, University of California, Irvine, Orange, CA, USA.
Department of Neurological Surgery, University of California, Irvine, Orange, CA, USA.
Asian Spine J. 2025 Aug;19(4):507-515. doi: 10.31616/asj.2024.0350. Epub 2025 Jun 24.
A retrospective cohort study.
We present data assessing the differences in 30-day morbidity, mortality, and postoperative complications between the two surgical remedy options.
The choice between decompression with fusion or decompression alone for the management of cervical spondylotic myelopathy (CSM) remains controversial.
The American College of Surgeons National Quality Improvement Program database was queried for adults ≥18 years diagnosed with spondylosis with cervical myelopathy (10th revision of the International Classification of Diseases [ICD-10]: M47.12) or spinal stenosis of the cervical region (ICD-10: M48.02) who underwent laminectomy (Current Procedural Terminology [CPT] 63001, 63015, 63045) with or without fusion (CPT 22600) between 2015 and 2020. Patients were stratified into fusion and non-fusion cohorts for comparative review. Estimated 30-day mortality and morbidity, postoperative complications, and American Society of Anesthesiologists (ASA) classification were evaluated using chi-square and analysis of variance tests, and results were further stratified according to ASA classification.
Of the 6,412 patients, 3,355 (52%) received laminectomy without fusion, and 3,057 (48%) experienced laminectomy with fusion. Patients undergoing decompression with fusion had higher mean morbidity (estimated probability 0.073 vs. 0.064, p<0.001), unplanned reoperations (4.2% vs. 2.7%, p<0.002), unplanned readmissions (7.6% vs. 6.3%, p<0.014), mean length of stay (5.0±8.9 days vs. 3.4±7.2 days, p<0.001), deep wound infections (0.8% vs. 0.4%, p<0.022), and bleeding risk necessitating transfusion (3.8% vs. 1.6%, p<0.001). Stratification by ASA scores demonstrated an overall higher rate of 30-day postoperative complications with increasing ASA scores in both cohorts, However, the decompression with fusion cohort showed a greater relative increase in complications compared to the decompression-alone cohort with each ASA group.
Decompression with fusion is correlated with higher estimated morbidity, unplanned reoperations and readmissions, and 30-day complications postoperatively. Decompression alone is an appealing procedure option for CSM, particularly for patients with higher ASA scores and those at greater risk.
一项回顾性队列研究。
我们展示数据以评估两种手术治疗方案在30天发病率、死亡率及术后并发症方面的差异。
对于脊髓型颈椎病(CSM)的治疗,选择减压融合术还是单纯减压术仍存在争议。
查询美国外科医师学会国家质量改进计划数据库,纳入2015年至2020年间年龄≥18岁、诊断为颈椎病伴脊髓病(国际疾病分类第10版[ICD - 10]:M47.12)或颈椎管狭窄(ICD - 10:M48.02)并接受了椎板切除术(现行手术操作术语[CPT] 63001、63015、63045)且有或无融合术(CPT 22600)的患者。将患者分为融合术组和非融合术组进行对比分析。采用卡方检验和方差分析评估预计的30天死亡率和发病率、术后并发症及美国麻醉医师协会(ASA)分级,并根据ASA分级对结果进一步分层。
6412例患者中,3355例(52%)接受了单纯椎板切除术,3057例(48%)接受了融合术。接受减压融合术的患者平均发病率更高(预计概率0.073对0.064,p<0.001)、计划外再次手术率更高(4.2%对2.7%,p<0.002)、计划外再入院率更高(7. +%对6.3%,p<0.014)、平均住院时间更长(5.0±8.9天对3.4±7.2天,p<0.001)、深部伤口感染率更高(0.8%对0.4%,p<0.022)以及因出血风险需要输血的比例更高(3.8%对1.6%,p<0.001)。根据ASA评分分层显示,两个队列中30天术后并发症总体发生率均随ASA评分增加而升高,然而,与单纯减压术队列相比,融合减压术队列在每个ASA组中并发症的相对增加幅度更大。
减压融合术与更高的预计发病率、计划外再次手术和再入院率以及术后30天并发症相关。单纯减压术是CSM一种有吸引力的手术选择,尤其对于ASA评分较高及风险较大的患者。